Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$272.7M
-12.5% from 2023
Prescriptions
21K
$12,735.41 per claim
Patients
2,983
2,472 prescribers
Total spending, 2024
$272.7M
$91,419.16 per patient
Medicare prescription drug plans paid $272.7M for Ninlaro in 2024, for 21,413 prescriptions and refills to 2,983 patients (down 12.5% from 2023). The average cost per claim was $12,735.41.
California had the highest Medicare cost for Ninlaro in 2024: $29.2M for 2,270 claims, followed by New York ($26.0M).
Patricia L Kropf, hematology in Charlotte, NC, had the highest Medicare cost for Ninlaro in 2024: 179 claims costing $2.3M.
Ninlaro is made by Takeda Pharmaceutical Company Limited (TAK), listed in the Medicare spending data as Takeda Pharmace.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Patricia L Kropf Charlotte, NC | Hematology | 179 | 18 | $2.3M |
| Ajay K Nooka Atlanta, GA | Hematology-Oncology | 101 | 12 | $1.3M |
| Jason Valent |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 3,025 | 28,258 | 3,985 | $340.7M |
| 2023 | 2,740 | 23,984 | 3,380 | $311.8M |
| 2024 | 2,472 | 21,413 | 2,983 | $272.7M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 83 |
| 14 |
| $1.1M |
| Donald S Gravenor Memphis, TN | Medical Oncology | 68 | Under 11 | $863K |
| Katie Jones New York, NY | Nurse Practitioner | 67 | Under 11 | $858K |
| Suzanne L Kirby Cary, NC | Hematology-Oncology | 63 | Under 11 | $851K |
| Jonathan L Kaufman Atlanta, GA | Hematology-Oncology | 64 | Under 11 | $800K |
| Teresa Fogaren Boston, MA | Nurse Practitioner | 62 | 11 | $784K |
| Larry D Anderson Jr. Dallas, TX | Hematopoietic Cell Transplantation and Cellular Therapy | 61 | Under 11 | $771K |
| Muhammad A Hussain Albany, NY | Hematology-Oncology | 55 | Under 11 | $751K |
| Kiran K Yalamanchili Lubbock, TX | Hematology-Oncology | 58 | Under 11 | $746K |
| Adam F Binder Philadelphia, PA | Medical Oncology | 57 | 11 | $729K |
| Amanda Buck Little Rock, AR | Nurse Practitioner | 57 | 12 | $723K |
| Robert A Vescio Los Angeles, CA | Hematology-Oncology | 63 | Under 11 | $710K |
| Saulius K Girnius Montgomery, OH | Hematology-Oncology | 55 | Under 11 | $709K |
| Lihong Wu Long Beach, CA | Hematology-Oncology | 59 | Under 11 | $703K |
| Jan S Moreb Winston Salem, NC | Hematology-Oncology | 55 | Under 11 | $703K |
| Shahrooz Eshaghian Los Angeles, CA | Hematology-Oncology | 56 | Under 11 | $701K |
| Guangzhi Qu Jackson, MS | Hematology-Oncology | 57 | Under 11 | $694K |
| Chandravathi Loke Springfield, MA | Hematology | 55 | Under 11 | $689K |
| Ilan Shapira New York, NY | Medical Oncology | 55 | Under 11 | $683K |
| Waqas Rehman Flemington, NJ | Hematology-Oncology | 54 | Under 11 | $677K |
| Gina B Fries Rochester, NY | Physician Assistant | 52 | Under 11 | $668K |
| Nisha S Joseph Atlanta, GA | Medical Oncology | 52 | Under 11 | $665K |
| Jason Suh Paramus, NJ | Medical Oncology | 49 | Under 11 | $658K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Takeda Pharmace TAK | 21,413 | $272.7M |